Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An Open Label, Registry Study of the Safety of Iluvien 190 Micrograms Intravitreal Implant in Applicator

X
Trial Profile

An Open Label, Registry Study of the Safety of Iluvien 190 Micrograms Intravitreal Implant in Applicator

Status: Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 04 May 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Fluocinolone acetonide (Primary)
  • Indications Diabetic macular oedema
  • Focus Adverse reactions
  • Acronyms IRISS
  • Sponsors Alimera Sciences
  • Most Recent Events

    • 28 Apr 2022 According to a Alimera Sciences media release, data from this trial will be presented at the annual Association for Research in Vision and Ophthalmology (ARVO) conference 2022.
    • 23 Oct 2017 Planned End Date changed from 1 Dec 2018 to 1 Jan 2020.
    • 23 Oct 2017 Planned primary completion date changed from 1 Dec 2018 to 1 Jan 2020.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top